mortality/aging
• slightly fewer (20.6%) than the expected (25%) numbers of mice are obtained, indicating a low rate of embryonic lethality or reduced postnatal viability
|
behavior/neurological
• mice exhibit an overall increase in the foot spacing consistent with a wide-spaced ataxic gait
• mice show a decrease in the stance time of all 4 limbs of locomotion and a trend toward increased front and rear paw swing time at 3 months of age
• however, mice exhibit normal performance on the rotarod at 4, 7, and 9 months of age
|
cellular
• cerebellar granule neurons show decreased susceptibility to radiomimetic-induced cell death, with more surviving cerebellar granule cells in cultures 20 hours after addition of doxorubicin
|
• fibroblasts grown in culture proliferate at a reduced rate compared to controls
• however, oxidative stress is not seen
|
• fibroblasts exhibit an altered DNA damage response
|
endocrine/exocrine glands
• mice rarely develop thymic lymphomas or other cancers, with 8% of mice succumbing to thymic lymphomas
|
hematopoietic system
• mice rarely develop thymic lymphomas or other cancers, with 8% of mice succumbing to thymic lymphomas
|
• increase in the percentage of B cells within the circulating lymphocyte populations at 2 and 5 months of age
|
• reduction in the percentage of T-cell subsets within the circulating lymphocyte population at 2 and 5 months of age
|
homeostasis/metabolism
• fibroblasts exhibit an altered DNA damage response
|
immune system
• mice rarely develop thymic lymphomas or other cancers, with 8% of mice succumbing to thymic lymphomas
|
• increase in the percentage of B cells within the circulating lymphocyte populations at 2 and 5 months of age
|
• reduction in the percentage of T-cell subsets within the circulating lymphocyte population at 2 and 5 months of age
|
neoplasm
• mice rarely develop thymic lymphomas or other cancers, with 8% of mice succumbing to thymic lymphomas
|
nervous system
N |
• no cellular defects are seen in the cerebellum
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
ataxia telangiectasia | DOID:12704 |
OMIM:208900 |
J:226414 |